Literature DB >> 12893881

Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in vitamin D receptor transactivation during keratinocyte differentiation.

Yuko Oda1, Carina Sihlbom, Robert J Chalkley, Lan Huang, Christophe Rachez, Chao-Pei Betty Chang, Alma L Burlingame, Leonard P Freedman, Daniel D Bikle.   

Abstract

Cell programs such as proliferation and differentiation involve the sequential activation and repression of gene expression. Vitamin D, via its active metabolite 1,25-dihydroxyvitamin D [1,25-(OH)2D3)], controls the proliferation and differentiation of a number of cell types, including keratinocytes, by directly regulating transcription. Two classes of coactivators, the vitamin D receptor (VDR)-interacting proteins (DRIP/mediator) and the p160 steroid receptor coactivator family (SRC/p160), control the actions of nuclear hormone receptors, including the VDR. However, the relationship between these two classes of coactivators is not clear. Using glutathione-S-transferase-VDR affinity beads, we have identified the DRIP/mediator complex as the major VDR binding complex in proliferating keratinocytes. After the cells differentiated, members of the SRC/p160 family were identified in the complex but not major DRIP subunits. Both DRIP and SRC proteins were expressed in keratinocytes. DRIP205 expression decreased during differentiation, although SRC-3 levels increased. Both DRIP205 and SRC-3 potentiated vitamin D-induced transcription in proliferating cells, but during differentiation, DRIP205 was no longer effective. These results indicate that these two distinct coactivators are sequentially involved in vitamin D regulation of gene transcription during keratinocyte differentiation, suggesting that these coactivators are part of the means by which the temporal sequence of gene expression is regulated during the differentiation process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893881     DOI: 10.1210/me.2003-0063

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  25 in total

Review 1.  The nonskeletal effects of vitamin D: an Endocrine Society scientific statement.

Authors:  Clifford J Rosen; John S Adams; Daniel D Bikle; Dennis M Black; Marie B Demay; JoAnn E Manson; M Hassan Murad; Christopher S Kovacs
Journal:  Endocr Rev       Date:  2012-05-17       Impact factor: 19.871

2.  Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation.

Authors:  Yuko Oda; Yoshikazu Uchida; Sam Moradian; Debra Crumrine; Peter M Elias; Daniel D Bikle
Journal:  J Invest Dermatol       Date:  2008-12-04       Impact factor: 8.551

Review 3.  Vitamin D and differentiation in cancer.

Authors:  Elzbieta Gocek; George P Studzinski
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

4.  Differential regulation of epidermal function by VDR coactivators.

Authors:  D D Bikle; A Teichert; L A Arnold; Y Uchida; P M Elias; Y Oda
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-16       Impact factor: 4.292

5.  The transcriptional coactivator DRIP/mediator complex is involved in vitamin D receptor function and regulates keratinocyte proliferation and differentiation.

Authors:  Yuko Oda; Robert J Chalkley; Alma L Burlingame; Daniel D Bikle
Journal:  J Invest Dermatol       Date:  2010-06-03       Impact factor: 8.551

Review 6.  Vitamin D metabolism and function in the skin.

Authors:  Daniel D Bikle
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

Review 7.  Vitamin D: newly discovered actions require reconsideration of physiologic requirements.

Authors:  Daniel D Bikle
Journal:  Trends Endocrinol Metab       Date:  2010-02-10       Impact factor: 12.015

Review 8.  Nonclassic actions of vitamin D.

Authors:  Daniel Bikle
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

Review 9.  An architectural perspective of vitamin D responsiveness.

Authors:  Martin Montecino; Gary S Stein; Fernando Cruzat; Sylvain Marcellini; Janet L Stein; Jane B Lian; Andre J van Wijnen; Gloria Arriagada
Journal:  Arch Biochem Biophys       Date:  2007-01-08       Impact factor: 4.013

10.  Steroid receptor coactivator 3 maintains circulating insulin-like growth factor I (IGF-I) by controlling IGF-binding protein 3 expression.

Authors:  Lan Liao; Xian Chen; Shu Wang; Albert F Parlow; Jianming Xu
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.